drugset / Trial / NCT00003737
Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Phase 2
Completed
30 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of rebeccamycin analog in treating children who have relapsed or refractory neuroblastoma.
Timeline
- Start
- 1999-01
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | becatecarin | Other / unclassified | — | Intravenous |